Pubertal hemorrhages in girls with a hemorrhagic disorder. Comments on management.
D000293:Adolescent; D000614:Aminocaproates / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000150:complications*; D001803:Blood Transfusion; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008234:Lynestrenol / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008535:Megestrol / Q000627:therapeutic use; D008595:Menorrhagia / Q000188:drug therapy*; D008656:Mestranol / Q000627:therapeutic use*; D010120:Oxytocics / Q000627:therapeutic use; D011278:Pregnanes / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*; D011627:Puberty; D014842:von Willebrand Diseases / Q000150:complications*
D000614:Aminocaproates; D006908:Hydroxyprogesterones; D010120:Oxytocics; D011278:Pregnanes; D011372:Progestins; D008656:Mestranol; D008535:Megestrol; D008274:Magnesium; D008234:Lynestrenol